2nd Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$314,770
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 20, 2011 $314,770 Replaced
2nd Quarter - Amendment Jan 26, 2012 $289,770 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pandemic and All-Hazards Preparedness Act (PAHPA) Reautorization in House and Senate. FY-2012 Funding for Biomedical Research and Development Authority (BARDA) at HHS. (Labor-HHS in Senate and and House Appropriations). Eductaion of Members of Congress and Staff on bioterrorism threat.

LobbyistCovered position, as disclosed
FRANCESCA COOK Sr. VP, Policy and Government Affairs
MARK EDWARD COOKE Senior Director Government Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.